# Role of Magnesium Sulphate as an Adjuvant to Bupivacaine in U.S Guided Quadratus Lumborum Block in Lower Abdominal Cancer Surgeries

> **NCT06301789** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 52 (estimated)

## Conditions studied

- QLB in Lower Abdominal Cancer Surgeries as a Post Operative Analgesia

## Interventions

- **DRUG:** Effect of adding Mg sulfate as an adjuvant to bupivacain in U/S guided QLB for postoperative analgesia in lower abdominal cancer surgeries

## Key facts

- **NCT ID:** NCT06301789
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-04
- **Primary completion:** 2026-02
- **Final completion:** 2026-03
- **Target enrollment:** 52 (ESTIMATED)
- **Last updated:** 2024-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06301789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06301789, "Role of Magnesium Sulphate as an Adjuvant to Bupivacaine in U.S Guided Quadratus Lumborum Block in Lower Abdominal Cancer Surgeries". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06301789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*